Identification of novel androgen receptor target genes in prostate cancer

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Jariwala, Unnati ^a   Prescott, Jennifer ^a   Jia, Li ^a   Barski, Artem ^a   Pregizer, Steve ^a   Cogan, Jon P ^a   Arasheben, Armin ^a   Tilley, Wayne D ^b   Scher, Howard I ^c   Gerald, William L ^c   Buchanan, Grant ^a,b   Coetzee, Gerhard A ^a   Frenkel, Baruch ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; DOPACHROME TAUTOMERASE; FLUTAMIDE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE T2; GOSERELIN; ORNITHINE OXOACID AMINOTRANSFERASE; PROTEIN KINASE C DELTA; PYRROLINE 5 CARBOXYLATE REDUCTASE; PYRROLINE 5 CARBOXYLATE REDUCTASE 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 3; ANDROGEN; CELL ADHESION MOLECULE; CRELD2 PROTEIN, HUMAN; DELTA 1 PYRROLINE 5 CARBOXYLATE REDUCTASE; DELTA-1-PYRROLINE-5-CARBOXYLATE REDUCTASE; GSTT2 PROTEIN, HUMAN; MRFAP1 PROTEIN, HUMAN; MUCIN; MUCIN 6; NUCLEAR PROTEIN; PRKCD PROTEIN, HUMAN; SCLEROPROTEIN; SIGNAL PEPTIDE; TRPV3 PROTEIN, HUMAN; TUMOR PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE LOCUS; GENE REPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENE TARGETING; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; METASTASIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECEPTOR OCCUPANCY; TRANSCRIPTION REGULATION; ADENOCARCINOMA; BINDING SITE; BIOSYNTHESIS; COMPARATIVE STUDY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN CHROMOSOME; METABOLISM; NEOPLASM; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANDROGENS; BINDING SITES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CHROMOSOMES, HUMAN; DIHYDROTESTOSTERONE; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUCINS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORNITHINE-OXO-ACID TRANSAMINASE; PROSTATIC NEOPLASMS; PROTEIN KINASE C-DELTA; PYRROLINE CARBOXYLATE REDUCTASES; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; TRPV CATION CHANNELS;

EID: 34447308493     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-39     Document Type: Article

References (72)

1. Hsing AW Chokkalingam AP Prostate cancer epidemiology Front Biosci 2006 11 1388-1413 10.2741/1891 16368524
2. Marker PC Donjacour AA Dahiya R Cunha GR Hormonal, cellular, and molecular control of prostatic development Dev Biol 2003 253 2 165-174 10.1016/S0012-1606(02)00031-3 12645922
3. Bonkhoff H Remberger K Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model Prostate 1996 28 2 98-106 10.1002/ (SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J 8604398
4. Geck P Szelei J Jimenez J Lin TM Sonnenschein C Soto AM Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells J Steroid Biochem Mol Biol 1997 63 4-6 211-218 10.1016/S0960-0760(97)00122-2 9459187
5. Scher HI Buchanan G Gerald W Butler LM Tilley WD Targeting the androgen receptor: Improving outcomes for castration-resistant prostate cancer Endocr Relat Cancer 2004 11 3 459 476 10.1677/erc.1.00525 15369448
6. Balk SP Androgen receptor as a target in androgen-independent prostate cancer Urology 2002 60 3 Suppl 1 132-138 discussion 138-139. 10.1016/ S0090-4295(02)01593-5 12231070
7. Buchanan G Irvine RA Coetzee GA Tilley WD Contribution of the androgen receptor to prostate cancer predisposition and progression Cancer Metastasis Rev 2001 20 3-4 207-223 10.1023/A:1015531326689 12085963
8. Zegarra-Moro OL Schmidt LJ Huang H Tindall DJ Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells Cancer Res 2002 62 4 1008-1013 11861374
9. Chen CD Welsbie DS Tran C Baek SH Chen R Vessella R Rosenfeld MG Sawyers CL Molecular determinants of resistance to antiandrogen therapy Nat Med 2004 10 1 33-39 10.1038/nm972 14702632
10. Han G Buchanan G Ittmann M Harris JM Yu X Demayo FJ Tilley W Greenberg NM Mutation of the androgen receptor causes oncogenic transformation of the prostate Proc Natl Acad Sci USA 2005 102 4 1151-1156 544619 15657128 10.1073/pnas.0408925102
11. Borgono CA Diamandis EP The emerging roles of human tissue kallikreins in cancer Nat Rev Cancer 2004 4 11 876-890 10.1038/nrc1474 15516960
12. Whitbread AK Veveris-Lowe TL Lawrence MG Nicol DL Clements JA The role of kallikrein-related peptidases in prostate cancer: Potential involvement in an epithelial to mesenchymal transition Biol Chem 2006 387 6 707-714 10.1515/BC.2006.089 16800731
13. Gnanapragasam VJ Robson CN Neal DE Leung HY Regulation of FGF8 expression by the androgen receptor in human prostate cancer Oncogene 2002 21 33 5069-5080 10.1038/sj.onc.1205663 12140757
14. Gregory CW Hamil KG Kim D Hall SH Pretlow TG Mohler JL French FS Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes Cancer Res 1998 58 24 5718-5724 9865729
15. Xu LL Shi Y Petrovics G Sun C Makarem M Zhang W Sesterhenn IA McLeod DG Sun L Moul JW PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression Cancer Res 2003 63 15 4299-4304 12907594
16. Lin B Ferguson C White JT Wang S Vessella R True LD Hood L Nelson PS Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2 Cancer Res 1999 59 17 4180-4184 10485450
17. Tomlins SA Mehra R Rhodes DR Smith LR Roulston D Helgeson BE Cao X Wei JT Rubin MA Shah RB TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer Cancer Res 2006 66 7 3396-3400 10.1158/ 0008-5472.CAN-06-0168 16585160
18. Tomlins SA Rhodes DR Perner S Dhanasekaran SM Mehra R Sun XW Varambally S Cao X Tchinda J Kuefer R Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 2005 310 5748 644-648 10.1126/science.1117679 16254181
19. Barski A Frenkel B ChIP Display: Novel method for identification of genomic targets of transcription factors Nucleic Acids Res 2004 32 12 e104 484196 15252151 10.1093/nar/gnh097
20. Thalmann GN Anezinis PE Chang SM Zhau HE Kim EE Hopwood VL Pathak S von Eschenbach AC Chung LW Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer Cancer Res 1994 54 10 2577-2581 8168083
21. Prescott J Jariwala U Jia L Cogan JP Barski A Pregizer S Arasheben A Neilson JJ Frenkel B Coetzee GA Androgen Receptor-Mediated Repression of Novel Target Genes The Prostate 2007
22. Jia L Shen HC Wantroba M Khalid O Liang G Wang Q Gentzschein E Pinski JK Stanczyk FZ Jones PA Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells Mol Cell Biol 2006 26 19 7331-7341 1592894 16980632 10.1128/ MCB.00581-06
23. Jia L Kim J Shen H Clark PE Tilley WD Coetzee GA Androgen receptor activity at the prostate specific antigen locus: Steroidal and non-steroidal mechanisms Mol Cancer Res 2003 1-5 385-392 12651911
24. Holzbeierlein J Lal P LaTulippe E Smith A Satagopan J Zhang L Ryan C Smith S Scher H Scardino P Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance Am J Pathol 2004 164 1 217-227 1602218 14695335
25. Scher HI Sawyers CL Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis J Clin Oncol 2005 23 32 8253-8261 10.1200/ JCO.2005.03.4777 16278481
26. Rennie PS Bruchovsky N Leco KJ Sheppard PC McQueen SA Cheng H Snoek R Hamel A Bock ME MacDonald BS Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene Mol Endocrinol 1993 7 1 23-36 10.1210/me.7.1.23 8446105
27. Murtha P Tindall DJ Young CY Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5′ promoter region of the gene Biochemistry 1993 32 25 6459-6464 10.1021/bi00076a020 7686046
28. Riegman PH Vlietstra RJ van der Korput JA Brinkmann AO Trapman J The promoter of the prostate-specific antigen gene contains a functional androgen responsive element Mol Endocrinol 1991 5 12 1921-1930 1724287
29. Carroll JS Meyer CA Song J Li W Geistlinger TR Eeckhoute J Brodsky AS Keeton EK Fertuck KC Hall GF Genome-wide analysis of estrogen receptor binding sites Nat Genet 2006 38 11 1289-1297 10.1038/ng1901 17013392
30. Wei CL Wu Q Vega VB Chiu KP Ng P Zhang T Shahab A Yong HC Fu Y Weng Z A global map of p53 transcription-factor binding sites in the human genome Cell 2006 124 1 207-219 10.1016/j.cell.2005.10.043 16413492
31. Wang Q Carroll JS Brown M Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking Mol Cell 2005 19 5 631-642 10.1016/ j.molcel.2005.07.018 16137620
32. Spilianakis CG Lalioti MD Town T Lee GR Flavell RA Interchromosomal associations between alternatively expressed loci Nature 2005 435 7042 637-645 10.1038/nature03574 15880101
33. Willingham AT Gingeras TR TUF love for "junk" DNA Cell 2006 125 7 1215-1220 10.1016/j.cell.2006.06.009 16814704
34. Nelson PS Clegg N Arnold H Ferguson C Bonham M White J Hood L Lin B The program of androgen-responsive genes in neoplastic prostate epithelium Proc Natl Acad Sci USA 2002 99 18 11890-11895 129364 12185249 10.1073/ pnas.182376299
35. Xu LL Su YP Labiche R Segawa T Shanmugam N McLeod DG Moul JW Srivastava S Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes Int J Cancer 2001 92 3 322-328 10.1002/ijc.1196 11291065
36. Ernst T Hergenhahn M Kenzelmann M Cohen CD Bonrouhi M Weninger A Klaren R Grone EF Wiesel M Gudemann C Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue Am J Pathol 2002 160 6 2169-2180 1850818 12057920
37. Cawley S Bekiranov S Ng HH Kapranov P Sekinger EA Kampa D Piccolboni A Sementchenko V Cheng J Williams AJ Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs Cell 2004 116 4 499-509 10.1016/ S0092-8674(04)00127-8 14980218
38. Horak CE Snyder M ChIP-chip: A genomic approach for identifying transcription factor binding sites Methods Enzymol 2002 350 469-483 12073330
39. Ren B Robert F Wyrick JJ Aparicio O Jennings EG Simon I Zeitlinger J Schreiber J Hannett N Kanin E Genome-wide location and function of DNA binding proteins Science 2000 290 5500 2306-2309 10.1126/ science.290.5500.2306 11125145
40. Chen J Sadowski I Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements Proc Natl Acad Sci USA 2005 102 13 4813-4818 555698 15781865 10.1073/ pnas.0407069102
41. Kim J Bhinge AA Morgan XC Iyer VR Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment Nat Methods 2005 2 1 47-53 10.1038/nmeth726 15782160
42. Roh TY Ngau WC Cui K Landsman D Zhao K High-resolution genome-wide mapping of histone modifications Nat Biotechnol 2004 22 8 1013-1016 10.1038/nbt990 15235610
43. Impey S McCorkle SR Cha-Molstad H Dwyer JM Yochum GS Boss JM McWeeney S Dunn JJ Mandel G Goodman RH Defining the CREB regulon: A genome-wide analysis of transcription factor regulatory regions Cell 2004 119 7 1041-1054 15620361
44. van Steensel B Henikoff S Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase Nat Biotechnol 2000 18 4 424-428 10.1038/74487 10748524
45. Haag P Bektic J Bartsch G Klocker H Eder IE Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells J Steroid Biochem Mol Biol 2005 96 3-4 251-258 10.1016/ j.jsbmb.2005.04.029 15982869
46. Chang HC Chen SC Chen J Hsieh JT In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line J Formos Med Assoc 2005 104 9 652-658 16276440
47. Li P Yu X Ge K Melamed J Roeder RG Wang Z Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer Am J Pathol 2002 161 4 1467 1474 1867282 12368219
48. Magee JA Chang LW Stormo GD Milbrandt J Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element Endocrinology 2006 147 1 590-598 10.1210/en.2005-1001 16210365
49. Maxwell SA Davis GE Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines Proc Natl Acad Sci USA 2000 97 24 13009-13014 27169 11069295 10.1073/pnas.230445997
50. Chen C Dickman MB Proline suppresses apoptosis in the fungal pathogen Colletotrichum trifolii Proc Natl Acad Sci USA 2005 102 9 3459-3464 552905 15699356 10.1073/pnas.0407960102
51. Kiley SC Clark KJ Goodnough M Welch DR Jaken S Protein kinase C delta involvement in mammary tumor cell metastasis Cancer Res 1999 59 13 3230-3238 10397270
52. Kharait S Dhir R Lauffenburger D Wells A Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells Biochem Biophys Res Commun 2006 343 3 848-856 16564022
53. Fujii T Garcia-Bermejo ML Bernabo JL Caamano J Ohba M Kuroki T Li L Yuspa SH Kazanietz MG Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta J Biol Chem 2000 275 11 7574-7582 10.1074/jbc.275.11.7574 10713064
54. Sumitomo M Ohba M Asakuma J Asano T Kuroki T Asano T Hayakawa M Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells J Clin Invest 2002 109 6 827-836 150911 11901191 10.1172/JCI200214146
55. Tanaka Y Gavrielides MV Mitsuuchi Y Fujii T Kazanietz MG Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway J Biol Chem 2003 278 36 33753-33762 10.1074/jbc.M303313200 12824193
56. Ortiz JA Castillo M del Toro ED Mulet J Gerber S Valor LM Sala S Sala F Gutierrez LM Criado M The cysteine-rich with EGF-like domains 2 (CRELD2) protein interacts with the large cytoplasmic domain of human neuronal nicotinic acetylcholine receptor alpha4 and beta2 subunits J Neurochem 2005 95 6 1585-1596 10.1111/j.1471-4159.2005.03473.x 16238698
57. Nishihira J Fujinaga M Kuriyama T Suzuki M Sugimoto H Nakagawa A Tanaka I Sakai M Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation Biochem Biophys Res Commun 1998 243 2 538-544 10.1006/bbrc.1998.8123 9480844
58. Hollingsworth MA Swanson BJ Mucins in cancer: Protection and control of the cell surface Nat Rev Cancer 2004 4 1 45-60 10.1038/nrc1251 14681689
59. Velcich A Yang W Heyer J Fragale A Nicholas C Viani S Kucherlapati R Lipkin M Yang K Augenlicht L Colorectal cancer in mice genetically deficient in the mucin Muc2 Science 2002 295 5560 1726 1729 10.1126/ science.1069094 11872843
60. Schwarz EC Wissenbach U Niemeyer BA Strauss B Philipp SE Flockerzi V Hoth M TRPV6 potentiates calcium-dependent cell proliferation Cell Calcium 2006 39 2 163-173 10.1016/j.ceca.2005.10.006 16356545
61. Fixemer T Wissenbach U Flockerzi V Bonkhoff H Expression of the Ca2+ ctive cation channel TRPV6 in human prostate cancer: A novel prognostic marker for tumor progression Oncogene 2003 22 49 7858-7861 10.1038/ sj.onc.1206895 14586412
62. Hayes JD Pulford DJ The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit Rev Biochem Mol Biol 1995 30 6 445-600 8770536
63. Xu J Zheng SL Chang B Smith JR Carpten JD Stine OC Isaacs SD Wiley KE Henning L Ewing C Linkage of prostate cancer susceptibility loci to chromosome 1 Hum Genet 2001 108 4 335-345 10.1007/s004390100488 11379880
64. Freedman ML Haiman CA Patterson N McDonald GJ Tandon A Waliszewska A Penney K Steen RG Ardlie K John EM Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men Proc Natl Acad Sci USA 2006 103 38 14068-14073 1599913 16945910 10.1073/pnas.0605832103
65. Ensembl http://www.ensembl.org
66. Consite http://www.phylofoot.org/consite
67. Ouyang X DeWeese TL Nelson WG Abate-Shen C Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis Cancer Res 2005 65 15 6773-6779 10.1158/0008-5472.CAN-05-1948 16061659
68. Yamaguchi M Yamamoto K Miura O Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis Genes Chromosomes Cancer 2003 38 3 269-273 10.1002/gcc.10283 14506703
69. Verras M Sun Z Roles and regulation of Wnt signaling and beta-catenin in prostate cancer Cancer Lett 2006 237 1 22-32 10.1016/ j.canlet.2005.06.004 16023783
70. Hewitt KJ Agarwal R Morin PJ The claudin gene family: Expression in normal and neoplastic tissues BMC Cancer 2006 6 186 1538620 16836752 10.1186/1471-2407-6-186
71. Ashraf N Zino S Macintyre A Kingsmore D Payne AP George WD Shiels PG Altered sirtuin expression is associated with node-positive breast cancer Br J Cancer 2006 95 8 1056-1061 10.1038/sj.bjc.6603384 17003781
72. Langley E Pearson M Faretta M Bauer UM Frye RA Minucci S Pelicci PG Kouzarides T Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence Embo J 2002 21 10 2383-2396 126010 12006491 10.1093/ emboj/21.10.2383